Redox proteins as targets for drugs development against pathogens

Area of Science:

• Microbiology
• Biochemistry
• Drug Discovery

Background:

• Antimicrobial drug resistance and multi-resistant microbial strains pose increasing global health threats.
• Existing antibiotic treatments are losing effectiveness, and novel antimicrobial therapies are urgently needed for neglected and complex infectious diseases.
• Redox metabolism presents a promising target for developing new antimicrobial drugs.

Purpose of the Study:

• To review three key redox metabolic pathways—non-mevalonate pathway for isoprenoids biosynthesis, iron metabolism, and iron-sulfur proteins—as potential targets for novel antimicrobial drug development.
• To highlight the plant-type ferredoxin-NADP+ reductase as a common link in these pathways with no human homolog, making it an attractive target for selective drug design.

Main Methods:

• Literature review focusing on redox metabolism in microbial pathogens.
• Analysis of the non-mevalonate pathway, iron metabolism, and iron-sulfur proteins.
• Identification of plant-type ferredoxin-NADP+ reductase as a potential drug target.

Main Results:

• Several redox metabolic pathways and their components are essential for microbial pathogen survival.
• The non-mevalonate pathway, iron metabolism, and iron-sulfur proteins are identified as promising targets.
• Plant-type ferredoxin-NADP+ reductase, lacking a human homolog, is a key enzyme in these pathways.

Conclusions:

• Targeting specific redox metabolic pathways offers a rational approach to designing novel antimicrobial drugs.
• Further research into these pathways, particularly focusing on plant-type ferredoxin-NADP+ reductase, can lead to new treatments against drug-resistant pathogens.
• This strategy holds promise for combating infectious diseases, including those caused by neglected or complex organisms.